BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9690919)

  • 1. Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency.
    Sich D; Saïdi Y; Giral P; Lagrost L; Dallongeville J; Federspiel MC; Cherfils C; Raisonnier A; Turpin G; Beucler I
    Atherosclerosis; 1998 Jun; 138(2):351-60. PubMed ID: 9690919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity.
    Sich D; Saïdi Y; Giral P; Lagrost L; Egloff M; Auer C; Gautier V; Turpin G; Beucler I
    Metabolism; 1998 Aug; 47(8):965-73. PubMed ID: 9711993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase.
    Mowri HO; Patsch JR; Ritsch A; Föger B; Brown S; Patsch W
    J Lipid Res; 1994 Feb; 35(2):291-300. PubMed ID: 8169533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay.
    Nagano M; Yamashita S; Hirano K; Ito M; Maruyama T; Ishihara M; Sagehashi Y; Oka T; Kujiraoka T; Hattori H; Nakajima N; Egashira T; Kondo M; Sakai N; Matsuzawa Y
    J Lipid Res; 2002 Jul; 43(7):1011-8. PubMed ID: 12091484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia.
    Maruyama T; Sakai N; Ishigami M; Hirano K; Arai T; Okada S; Okuda E; Ohya A; Nakajima N; Kadowaki K; Fushimi E; Yamashita S; Matsuzawa Y
    Atherosclerosis; 2003 Jan; 166(1):177-85. PubMed ID: 12482565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.
    Hirano K; Yamashita S; Kuga Y; Sakai N; Nozaki S; Kihara S; Arai T; Yanagi K; Takami S; Menju M
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1849-56. PubMed ID: 7583564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
    Kontush A; de Faria EC; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects.
    Arai T; Yamashita S; Sakai N; Hirano K; Okada S; Ishigami M; Maruyama T; Yamane M; Kobayashi H; Nozaki S; Funahashi T; Kameda-Takemura K; Nakajima N; Matsuzawa Y
    J Lipid Res; 1996 Oct; 37(10):2145-54. PubMed ID: 8906592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum apolipoprotein E-rich HDL-C levels in the subjects with hyperalphalipoproteinemia].
    Inano K; Miida T; Okada M
    Rinsho Byori; 1997 Sep; 45(9):903-7. PubMed ID: 9311266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point mutation (-69 G-->A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects.
    Nagano M; Yamashita S; Hirano K; Kujiraoka T; Ito M; Sagehashi Y; Hattori H; Nakajima N; Maruyama T; Sakai N; Egashira T; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):985-90. PubMed ID: 11397708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
    Tan KC; Shiu SW; Pang RW; Kung AW
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S; Hirano K; Sakai N; Matsuzawa Y
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of subclasses of HDL containing apoA-I without apoA-II (LpA-I) in normolipidemic men and women.
    Duverger N; Rader D; Brewer HB
    Arterioscler Thromb; 1994 Oct; 14(10):1594-9. PubMed ID: 7918309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
    Hirano K; Yamashita S; Nakajima N; Arai T; Maruyama T; Yoshida Y; Ishigami M; Sakai N; Kameda-Takemura K; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1053-9. PubMed ID: 9194754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia.
    Saïdi Y; Sich D; Camproux A; Egloff M; Federspiel MC; Gautier V; Raisonnier A; Turpin G; Beucler I
    Metabolism; 1999 Jan; 48(1):60-7. PubMed ID: 9920146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
    Yamashita S; Maruyama T; Hirano K; Sakai N; Nakajima N; Matsuzawa Y
    Atherosclerosis; 2000 Oct; 152(2):271-85. PubMed ID: 10998455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.
    Yamashita S; Sprecher DL; Sakai N; Matsuzawa Y; Tarui S; Hui DY
    J Clin Invest; 1990 Sep; 86(3):688-95. PubMed ID: 2118552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein.
    Tan KC; Shiu SW; Kung AW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2921-4. PubMed ID: 9709970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity.
    Groener JE; da Col PG; Kostner GM
    Biochem J; 1987 Feb; 242(1):27-31. PubMed ID: 3593240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity.
    Hirano K; Matsuzawa Y; Sakai N; Hiraoka H; Nozaki S; Funahashi T; Yamashita S; Kubo M; Tarui S
    Metabolism; 1992 Dec; 41(12):1313-8. PubMed ID: 1461137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.